Drs. Berrocal Reflect on ASRS 2026

• by Audina M. Berrocal, MD, Maria H. Berrocal, MD

• July 15, 2026

The Economics of Home OCT

At ASRS 2026, Sean Berkowitz, MD, MBA, examined the payer costs and physician workload associated with home OCT monitoring for wet AMD.

• by Jim Gallagher, senior managing editor

• July 15, 2026

• 4 min

Modeling Oxygen Saturation Targets, Mortality, and Retinopathy Among Extremely Preterm Infants

• by Brian C. King, John A. F. Zupancic, Erika M. Edwards, Danielle E. Y. Ehret, Jeffrey D. Horbar, Roger F. Soll, Barbara K. Schmidt

• July 21, 2026

Alkeus Launches Phase 3 Stargardt Trial

At OIS Retina, Carlos Quezada Ruiz, MD, highlighted the launch of the global phase 3 NORTHSTAR trial evaluating investigational oral gildeuretinol for Stargardt disease.

• by Carlos Quezada Ruiz, MD

• July 15, 2026

• 2 min